Sumitomo Pharma America, Inc.

This early-phase study tests an experimental oral drug called DSP-0390 in 39 adults whose high-grade glioma (a fast-growing brain tumor) has come back after prior treatment. The main goals are to check the drug's safety and find the best dose to use in future studies. Researchers…

This study follows about 1,000 prostate cancer patients who are taking ORGOVYX (relugolix) as part of their routine care. Researchers will track side effects, quality of life, and how the disease progresses over time. The goal is to see how well the drug works outside of controll…

This study follows 12 adults with severe retinitis pigmentosa, a genetic eye disease that causes vision loss. Researchers want to find out which vision tests people with very low sight can reliably perform and how their vision changes over one year. The goal is to improve future …